# Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus

> **NCT00483119** · PHASE2 · TERMINATED · sponsor: **NYU Langone Health** · enrollment: 9 (actual)

## Conditions studied

- Pemphigus Vulgaris

## Interventions

- **DRUG:** intravenous immunoglobulin
- **DRUG:** cyclophosphamide

## Key facts

- **NCT ID:** NCT00483119
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2010-02
- **Final completion:** 2011-02
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Study was terminated due to the death of the PI.
- **Last updated:** 2016-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00483119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00483119, "Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00483119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*